TSG101 antibody (AA 340-370)
-
- Target See all TSG101 Antibodies
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Binding Specificity
- AA 340-370
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This TSG101 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA
- Cross-Reactivity (Details)
- Expected species reactivity: Mouse, Rat
- Purification
- Purified
- Immunogen
- A portion of amino acids 340-370 from the human protein was used as the immunogen for this TSG101 antibody.
- Isotype
- Ig Fraction
- Top Product
- Discover our top product TSG101 Primary Antibody
-
-
- Application Notes
- Titration of the TSG101 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Aliquot the TSG101 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
- Target
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Alternative Name
- TSG101 (TSG101 Products)
- Background
- TSG101 belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.
- UniProt
- Q99816
-